![](/img/cover-not-exists.png)
Which is the optimal antiandrogen for use in combined androgen blockade of advanced prostate cancer? The transition from a first-to second-generation antiandrogen
Sarosdy, Michael FVolume:
10
Journal:
Anti-Cancer Drugs
DOI:
10.1097/00001813-199910000-00001
Date:
October, 1999
File:
PDF, 428 KB
1999